Hints and tips:
Related Topics
...Recent examples include GI Partners joining Allscripts Healthcare Solutions to buy Netsmart Technologies, the healthcare software and services provider....
...Brothers and worked on transactions including Heineken and Carlsberg’s $20.2bn break-up bid for Scottish & Newcastle, Coca-Cola Hellenic’s relisting, and Misys’ $1.3bn disposal of its listed subsidiary Allscripts...
...Even smaller companies saw similar successes, with Allscripts, a Chicago-based company that spent hundreds of thousands lobbying for the programme, seeing revenues spike more than 160 per cent....
...Pre-tax profit fell 28 per cent to £32.2m as Misys faced a number of exceptional charges and fees related to the acquisition of Sophis and the disposal of Allscripts, the company’s healthcare software business...
...Several established health companies, including Athenahealth and Allscripts, offer doctors a data server and software system to meet the requirement. Typical cost ranges from $44,000 to $64,000....
...A deal would follow the $1.3bn sale of Misys’s Allscripts healthcare business last year, and complete a five-year turnround of the business by Mike Lawrie, chief executive....
...His strategy of simplifying Misys by shedding its stake in Allscripts and focusing on banking, treasury and capital markets is starting to pay off....
...Glen Tullman, CEO of Allscripts, talks to Paul Taylor about how the use of technology in healthcare industry can improve the quality of care and reduce costs....
...Misys has been returning £670m of the proceeds of its Allscripts divestment to shareholders. It said the final £145m would be paid out during the fourth quarter....
...Misys, the financial software provider, is poised to acquire Irish rival Sophis for £235m with funds from the disposal of Allscripts, its healthcare arm....
...Last week Misys, the financial software provider, said it would acquire rival Sophis for £235m with funds from the disposal of its Allscripts healthcare arm....
...The sale of Misys’s majority stake in Allscripts is a fabulous return for two years’ work, according to the FT....
...The merger of Allscripts and Misys was central to the UK company’s turnround....
...By any calculation, the sale of Misys’s majority stake in Allscripts is a fabulous return for two years’ work....
...Precisely how good the latest deal is, depends on the price at which Misys places its Allscripts shares and the consummation of Allscripts’ merger with Eclipsys, another IT company....
...Related link: Misys moves to sell Allscripts stake – FT...
...It will retain a stake of about 8 to 10 per cent in the combined Allscripts-Eclipsys business....
...The precise outcome of the complex deal depends on various imponderables – including the price at which Misys places its shares in Allscripts and the consummation of Allscripts’ merger with Eclipsys, another...
...Misys owns 57 per cent of Allscripts, the US healthcare software company, and is expected to be a big beneficiary of the stimulus package, part of which is earmarked for helping doctors to modernise their...
...Breaking pre-market news on Wednesday, - Misys to sell majority of its controlling interest in Allscripts; to return proceeds of £800m to shareholders – statement....
...Misys agreed last month to sell most of its Allscripts stake at a minimum price of $16.50 with the transaction due to complete in October....
...Allscripts was 9.7 per cent lower at $16.64....
...Among the mid-caps, Misys added 3.7 per cent to 266p after its Allscripts subsidiary pushed ahead with a share issue as part of the sale of the division to Eclipsys....
...Earnings per share fell from 14.7p to 4.0p to reflect the shares issued to help fund the purchase of Allscripts, its US healthcare software division....
...Allscripts trades on Nasdaq at about 28 times earnings expectations....
International Edition